One would think that this must draw attention by itself, great news for mnd suffers, first treatment of its kind for MND and little to no adverse affects.
I thank all participants in the trial and also thank those who have and continue to carry out the trial.
A possible treatment I guess I should say, and developed by a small Australian company.
Come on big pharmas this had great potential not only for mnd but human cancer.
Ann: MND Biomarkers and Pharmacodynamics Results, page-61
-
- There are more pages in this discussion • 336 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $97.22M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.0¢ | 19.5¢ | $199.9K | 1.004M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 457971 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 1207 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |